The Department of Chemistry & Biochemistry, The University of Texas at El Paso, El Paso, TX 79968, USA.
Environment Science & Engineering department, The University of Texas at El Paso, El Paso, TX 79968, USA.
Molecules. 2018 Aug 27;23(9):2157. doi: 10.3390/molecules23092157.
While pharmaceutical drugs have revolutionized human life, there are several features that limit their full potential. This review draws attention to some of the obstacles currently facing the use of chemotherapeutic drugs including low solubility, poor bioavailability and high drug dose. Overcoming these issues will further enhance the applicability and potential of current drugs. An emerging technology that is geared towards improving overall therapeutic efficiency resides in drug delivery systems including the use of polymeric nanoparticles which have found widespread use in cancer therapeutics. These polymeric nanoparticles can provide targeted drug delivery, increase the circulation time in the body, reduce the therapeutic indices with minimal side-effects, and accumulate in cells without activating the mononuclear phagocyte system (MPS). Given the inroads made in the field of nanodelivery systems for pharmaceutical applications, it is of interest to review and emphasize the importance of Polymeric nanocarrier system for drug delivery in chemotherapy.
虽然制药业已经彻底改变了人类的生活,但它们仍存在一些限制其充分发挥潜力的特征。本文提请注意当前使用化疗药物所面临的一些障碍,包括低溶解度、生物利用度差和高药物剂量。克服这些问题将进一步提高现有药物的适用性和潜力。一种旨在提高整体治疗效率的新兴技术是药物传递系统,包括使用聚合物纳米粒子,这些粒子在癌症治疗中得到了广泛应用。这些聚合物纳米粒子可以提供靶向药物传递,增加在体内的循环时间,降低治疗指数,同时最小化副作用,并在不激活单核吞噬细胞系统 (MPS) 的情况下在细胞中积累。鉴于在制药应用的纳米传递系统领域取得的进展,回顾并强调聚合物纳米载体系统在化疗药物传递中的重要性是很有意义的。